Effectiveness of the 2023–2024 Omicron XBB.1.5-containing mRNA COVID-19 Vaccine (mRNA-1273.815) in Preventing COVID-19–related Hospitalizations and Medical Encounters Among Adults in the United States
2024

Effectiveness of the 2023–2024 Omicron XBB.1.5 COVID-19 Vaccine

Sample size: 1718670 publication 10 minutes Evidence: high

Author Information

Author(s): Kopel Hagit, Araujo Andre B, Bogdanov Alina, Zeng Ni, Winer Isabelle, Winer-Jones Jessamine P, Lu Tianyi, Marks Morgan A, Bonafede Machaon, Nguyen Van Hung, Martin David, Mansi James A

Primary Institution: Moderna, Inc.

Hypothesis

This study aimed to evaluate the vaccine effectiveness of mRNA-1273.815 in preventing COVID-19-related hospitalizations and medical encounters among adults.

Conclusion

The mRNA-1273.815 vaccine provides significant protection against COVID-19-related hospitalizations and medically attended COVID-19 in adults.

Supporting Evidence

  • Vaccine effectiveness was 60.2% against COVID-19-related hospitalizations.
  • Vaccine effectiveness was 33.1% against medically attended COVID-19.
  • Results were consistent across subpopulations including older adults and those with underlying conditions.

Takeaway

The new COVID-19 vaccine helps keep people from getting really sick and needing to go to the hospital.

Methodology

A retrospective cohort study using linked electronic health record and claims data to compare vaccinated and unvaccinated adults.

Potential Biases

Potential residual confounding may exist due to unmeasured characteristics.

Limitations

The study may not be generalizable to uninsured individuals and is subject to selection bias due to its nonrandomized nature.

Participant Demographics

Mean age was 63 years; 57% were female, and over 60% had underlying medical conditions.

Statistical Information

P-Value

0.0001

Confidence Interval

95% CI: 53.4–66.0 for hospitalizations; 30.2–35.9 for medically attended COVID-19

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1093/ofid/ofae695

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication